companiesSEC EDGAR
ArriVent BioPharma, Inc.
SEC EDGAR published this disclosure on 2026-10-19. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001104659-26-116736
cik1868279
company nameArriVent BioPharma, Inc.
form8-K